NK

Nanki Kaur

Active Director Director DIN 10752906
DIN 10752906 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Nanki Kaur

Data last updated:

Nanki Kaur is a Director at Mitis Biomedics Limited (since 2024). The company operates in Pharma. Mitis Biomedics Limited reported revenue of ₹6.16 Cr (FY 2024).

DIN 10752906
Primary Designation Director
Industry Pharma
First Appointment 26 Aug 2024
Oldest Company Age 11 yrs
Largest company Mitis Biomedics Limited · ₹6.16 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mitis Biomedics Limited U51909DL2015PLC280497
Director26 Aug 20242015₹6.16 Cr (FY 2024)Active

Board colleagues of Nanki Kaur

Directorship timeline

Open interactive timeline →
Mitis Biomedics Limited
Premium access

Shareholding and investment profile for Nanki Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanki Kaur

Nanki Kaur currently holds 1 directorship: Mitis Biomedics Limited (Director, since 26 Aug 2024, revenue ₹6.16 Cr (FY 2024)).

Nanki Kaur was first appointed on 26 Aug 2024 as Director at Mitis Biomedics Limited.

The current boards of Nanki Kaur's companies include Dil Mohan Singh (Mitis Biomedics Limited), Gagan Deep Singh (Mitis Biomedics Limited), Inderjeet Kaur (Mitis Biomedics Limited), Nitika (Mitis Biomedics Limited), Rijak Singh (Mitis Biomedics Limited), Taran Deep Singh (Mitis Biomedics Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available